
Ecopia BioSciences Inc. — Investor Relations & Filings
Ecopia BioSciences Inc. is a biotechnology company specializing in the research and development of novel therapeutic solutions, primarily focusing on drug discovery. The company's core strategy involves identifying and developing anticancer agents derived from microorganisms, recognized as a historically prolific source of pharmaceutical compounds. Ecopia's pipeline includes lead drug candidate ECO-4601, an anticancer compound that has reached key patent milestones, and other candidates such as CAPTAT-414. The company leverages specialized R&D platforms for the development of organism and botanical-derived drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2007-04-11 | English | |
| Material change report - French.pdf | 2007-01-15 | English | |
| Material change report - English.pdf | 2007-01-05 | English | |
| Material change report - English.pdf | 2006-09-05 | English | |
| Material change report - English.pdf | 2006-07-14 | English | |
| Material change report - English.pdf | 2006-05-24 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Jeevan Scientific Technology Limited
A CRO providing Phase I-IV trials, BA/BE research, and phar…
|
538837 | IN | Professional, scientific and te… |
|
J. Molner AS
A CDRO developing generic sterile injectable and dermatolog…
|
JML | EE | Professional, scientific and te… |
|
JOINN Laboratories (China) Co., Ltd.
Comprehensive CRO providing end-to-end preclinical drug dis…
|
6127 | HK | Professional, scientific and te… |
|
JOINN LABORATORIES (CHINA) CO., LTD.
A CRO specializing in non-clinical safety assessment and ph…
|
603127 | CN | Professional, scientific and te… |
|
Kadimastem Ltd.
Clinical-stage cell therapy company developing treatments f…
|
KDST | IL | Professional, scientific and te… |
|
KAINOS MEDICINE, INC.
Develops small molecule therapeutics for neurodegenerative,…
|
284620 | KR | Professional, scientific and te… |
|
Kairos Pharma, LTD.
Develops oncology therapies targeting drug resistance and i…
|
KAPA | US | Professional, scientific and te… |
|
Kancera
Pharmaceutical company seeking a reverse takeover to levera…
|
KAN | SE | Professional, scientific and te… |
|
KAZIA THERAPEUTICS LTD
Oncology-focused biotech developing targeted therapies for …
|
KZIA | US | Professional, scientific and te… |
|
Keros Therapeutics, Inc.
Develops protein therapeutics for disorders linked to TGF-β…
|
KROS | US | Professional, scientific and te… |
Ecopia BioSciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45024/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45024 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45024 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45024 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45024}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ecopia BioSciences Inc. (id: 45024)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.